{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?ddpModified.=2016-07-04T14%3A27%3A14.807Z&hansardHeading=Human+Papillomavirus%3A+Vaccination", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?ddpModified.=2016-07-04T14%3A27%3A14.807Z&hansardHeading=Human+Papillomavirus%3A+Vaccination", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?ddpModified.=2016-07-04T14%3A27%3A14.807Z&_metadata=all&hansardHeading=Human+Papillomavirus%3A+Vaccination", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&ddpModified.=2016-07-04T14%3A27%3A14.807Z&hansardHeading=Human+Papillomavirus%3A+Vaccination", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?ddpModified.=2016-07-04T14%3A27%3A14.807Z&hansardHeading=Human+Papillomavirus%3A+Vaccination", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?ddpModified.=2016-07-04T14%3A27%3A14.807Z&hansardHeading=Human+Papillomavirus%3A+Vaccination", "items" : [{"_about" : "http://data.parliament.uk/resources/521589", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/521589/answer", "answerText" : {"_value" : "

The Joint Committee on Vaccination and Immunisation\u2019s (JCVI) advice needs to be based on a robust cost-effectiveness analysis. This is underway and Public Health England is due to report by early 2017. The JCVI has agreed that shortcuts could undermine the validity of the results and will begin its deliberations on extending vaccination to adolescent boys once all the necessary evidence is available. It is important that we follow a proper process and that the JCVI has a full understanding of the cost-effectiveness of vaccination programmes.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2016-06-10", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2016-06-10T10:54:05.33Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2016-05-25", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Human Papillomavirus: Vaccination"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, if he will request that the Joint Committee on Vaccination and Immunisation undertakes an assessment of the recommendation from the Britain Against Cancer conference held in December 2015 to report its review on extending HPV vaccination to boys in 2016.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1506", "label" : {"_value" : "Biography information for Andrew Gwynne"} } , "tablingMemberConstituency" : {"_value" : "Denton and Reddish"} , "tablingMemberPrinted" : [{"_value" : "Andrew Gwynne"} ], "uin" : "38503"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 1, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }